• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchNuvectis Pharma
    Picture of Nuvectis Pharma logo

    NVCT — Nuvectis Pharma News Story

    $20.890.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    • Market Cap
      $680.63m
    • Enterprise Value
      $658.47m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NVCT Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NVCT Dividends
    All News

    NASDAQ RESUMED AT 11:48 AM

    Picture of Nuvectis Pharma logoNuvectis Pharma
    07/02/2022 16:48
    NASDAQ RESUMED  NVCT.O  AT 11:48 AM
    

    Recent news on Nuvectis Pharma

    See all news
    • Nuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary

      04/08/2026 14:35
    • Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview

      31/07/2026 13:02
    • Brief: Ciprocopan (NXP100) Receives Marketing Approval In China For The Treatment Of Patients With PNH Previously Untreated With Complement Inhibitors

      23/07/2026 13:14
    • U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox

      30/06/2026 18:39
    • U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin

      30/06/2026 16:44

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.